Key terms

About LH

Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest LH news

Mar 25 9:44am ET Tesla downgraded, Disney upgraded: Wall Street’s top analyst calls Mar 25 8:43am ET Argus upgrades Labcorp to Buy on stronger top-line growth, margin expansion Mar 25 7:26am ET Labcorp upgraded to Buy from Hold at Argus Mar 07 12:00am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Laboratory (LH), Apellis Pharmaceuticals (APLS) and Iovance Biotherapeutics (IOVA) Mar 05 7:11am ET Labcorp partners with Pinnacle Fertility Feb 27 11:40pm ET Analysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT), Celldex (CLDX) and Laboratory (LH) Feb 26 9:34am ET Moderna downgraded, Gap upgraded: Wall Street’s top analyst calls Feb 26 6:20am ET Labcorp initiated with an Outperform at Leerink Feb 21 8:21am ET Biomerica appoints Gary Huff to strategic advisory board Feb 19 12:45am ET Buy Rating for Laboratory Corp. as Strong Financials and Growth Prospects Shine Feb 16 7:10am ET Labcorp price target raised to $253 from $241 at Baird Feb 16 5:28am ET Labcorp price target raised to $234 from $222 at Barclays Feb 16 5:21am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sanofi (OtherSNYNF), Laboratory (LH) and Organon (OGN) Feb 15 7:07am ET Labcorp sees FY24 adjusted EPS $14.30-$15.40, consensus $14.60 Feb 15 7:04am ET Labcorp reports Q4 adjusted EPS $3.30, consensus $3.26 Feb 14 8:25pm ET Notable companies reporting before tomorrow’s open Feb 14 1:25pm ET Notable companies reporting before tomorrow’s open Feb 14 1:25pm ET Notable companies reporting before tomorrow’s open Feb 09 9:41am ET PayPal downgraded, United Airlines upgraded: Wall Street’s top analyst calls Feb 09 6:15am ET Labcorp initiated with an In Line at Evercore ISI Feb 07 9:06am ET Labcorp elevates employee health benefits with WeightWatchers Jan 31 7:16am ET Labcorp launches blood test for risk assesment of severe preeclampsia Jan 31 3:30am ET Wall Street Analysts Are Neutral on Top Healthcare Picks Jan 11 6:20am ET Labcorp price target raised to $241 from $239 at Baird Jan 10 8:04am ET Labcorp, Hawthorne Effect announce collaboration Jan 02 5:07pm ET Labcorp initiated with an Equal Weight at Barclays Dec 26 4:10pm ET SomaLogic corrects ‘Madryn Asset Management’s misleading disclosure’

No recent news articles are available for LH

No recent press releases are available for LH

LH Financials

1-year income & revenue

Key terms

LH Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

LH Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms